Exponential technologies will revolutionise healthcare, human longevity and wellness, and patient outcomes, and healthcare organisations need to be prepared.


Interested in the Exponential Future? Connect, download a free E-Book, watch a keynote, or browse my blog.

Firstly, thank you to Karen Taylor and the team at Deloitte for asking me to contribute and help them compile their latest Shaping the Future of UK Healthcare report, a copy of which you can find below.

As we look forwards to 2020 and beyond there is no doubt that increasingly democratised and powerful exponential technologies, which impact everything from the way healthcare services are consumed and delivered through to their impact on primary and secondary care treatments and processes, are not just going to have huge implications for the healthcare sector as a whole but they’re also going to play a transformative role in helping people live longer healthier lives and creating better patient outcomes.


Featured Futurist: Change the Abstract, Sopra Steria


From ground breaking in vivo gene editing treatments that have the potential to cure over 6,000 currently uncurable inherited genetic conditions through to 3D printing human organs and eliminating organ donation, both of which are just the tip of the metaphorical iceberg, the only way to describe what lies ahead of us, healthcare wise at least, is that we will increasingly see science fiction become science fact. And we need to be prepared to take full advantage of it.

However, as the pace of technological progress accelerates at an increasingly furious pace the healthcare sector’s ability to reap the benefits of these advances is going to be pushed to the limits so it’s imperative that governments, insurers, organisations, and regulators, as well as the rest of the healthcare ecosystem, act now to ensure they have the right operational and organisational models in place that will help them future proof themselves and expedite the adoption of these new technologies and capabilities as soon as they come to market.


CRISPR gene editing tool shown to stop Coronavirus replication in human cells


Furthermore, and most importantly, the sooner the insights in this report are addressed and adopted the sooner patients and their families can realise the benefits too.

You can download and read the full report below:



Source: Deloitte

About author

Matthew Griffin

Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the World Futures Forum and the 311 Institute, a global Futures and Deep Futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future” series. Regularly featured in the global media, including AP, BBC, Bloomberg, CNBC, Discovery, RT, Viacom, and WIRED, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Aon, Bain & Co, BCG, Credit Suisse, Dell EMC, Dentons, Deloitte, E&Y, GEMS, Huawei, JPMorgan Chase, KPMG, Lego, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, T-Mobile, and many more.

Your email address will not be published. Required fields are marked *